Search Results 371-380 of 24185 for In situ

1. A Study to Evaluate Pembrolizumab, Ixazomib Citrate, and Dexamethasone to Treat Participants with Relapsed Multiple Myeloma - Mayo Clinic

   Drugs used in chemotherapy, such as dexamethasone, work in different ... in situ breast cancer that has undergone potentially curative therapy. Any ...

2. Study of Adjuvant Regorafenib vs Placebo in Patients with Node Positive Esophageal Cancer who Completed Pre-operative Therapy - Mayo Clinic

   Prior cancers < 3 years, with the exception of in-situ cervical cancer, low grade prostate cancer and basal or squamous cell skin cancers. Subjects with ...

3. A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) - Mayo Clinic

   ... in situ of the uterine cervix that has been treated with no evidence of recurrence). Participants who have developed any major illness/condition or evidence ...

4. A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma - the ImmuneSense Study - Mayo Clinic

   squamous cell skin cancer, superficial bladder cancer, or carcinoma in situ of the cervix or breast that has completed curative therapy. - Has any severe ...

5. Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

   ... in-situ of the cervix; Previous treatment with chemotherapy or any other tyrosine kinase inhibitor for a hematological disorder; Exceptions: patients with ...

6. Individualized Temozolomide in Treating Patients with Stage IV Melanoma that Cannot be Removed by Surgery - Mayo Clinic

   Drugs used in chemotherapy, such as TMZ, work in different ways to stop ... in situ of the cervix; Known standard therapy for the patient's disease that ...

7. A Study to Evaluate Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients with Chronic Myeloid Leukemia and Persistently- Detectable Minimal Residual Disease - Mayo Clinic

   No other active primary malignancy (other than non-melanomatous skin cancer or carcinoma in situ ... in the preceding 24 consecutive months). ... in CMR in the last ...

8. Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant - Mayo Clinic

   Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in ... Any in situ cancer; Adequately treated stage I or II cancer from which the ...

9. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

   In situ cervical cancer that has undergone or will undergo potentially curative therapy;; Basal cell carcinoma, squamous cell carcinoma, melanoma of the skin ...

10. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

    ... in situ (DCIS) at the line of resection; additional operative procedures may be performed to obtain clear margins. Patients who had breast-conserving surgery ...